Kinga Boér

Title: Kinga Boér: Innovator in Adenosine A3 Ligands

Introduction

Kinga Boér is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of medicinal chemistry, particularly in the development of adenosine A3 receptor ligands. With a total of two patents to her name, her work has implications for various therapeutic applications.

Latest Patents

Kinga Boér's latest patents include "Imidazoquinoline derivatives and their use as adenosine A3 ligands." This invention relates to adenosine A3 receptor ligands of the general formula (I), focusing on antagonists and their pharmaceutical compositions. The patent also discusses the preparation of these compounds and their intermediates. Another significant patent is "Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands." This patent describes compounds where specific groups can be substituted, highlighting their potential as strong adenosine A3 receptor ligands, preferably antagonists.

Career Highlights

Kinga Boér is currently associated with Sanofi-Aventis, a leading global biopharmaceutical company. Her work at Sanofi-Aventis has allowed her to focus on innovative drug development, particularly in the area of receptor ligands.

Collaborations

Kinga collaborates with esteemed colleagues, including László Balázs and Mária Balogh, who contribute to her research efforts and innovations in the field.

Conclusion

Kinga Boér's contributions to the development of adenosine A3 ligands through her patents reflect her dedication to advancing medicinal chemistry. Her work continues to influence the pharmaceutical industry and offers promising avenues for future research.